Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bergstrand

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 2017
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-PiperaquineJesmin Permala, Joel Tarning, François Nosten, et al.
Science Translational Medicine|October 31, 2014
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemopreventionMartin Bergstrand, François Nosten, Khin Maung Lwin, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2018
Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in HumansBenjamin Guiastrennec, David P Sonne, Martin Bergstrand, et al.
Journal of Clinical Pharmacology|October 26, 2021
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic PurpuraMartin Bergstrand, Emma Hansson, Bernard Delaey, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 28, 2025
The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder PerspectiveMarylore Chenel, Sylvain Fouliard, Emma Hansson, et al.
Therapeutic Drug Monitoring|November 23, 2011
Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearanceJohan E Wallin, Martin Bergstrand, Henryk E Wilczek, et al.
Malaria Journal|March 24, 2018
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern MyanmarJesmin Permala Lohy Das, Myat P Kyaw, Myat H Nyunt, et al.
The AAPS Journal|December 11, 2012
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patientsDinko Rekić, Daniel Röshammar, Martin Bergstrand, et al.
The AAPS Journal|September 13, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast AsiaJesmin Lohy Das, Arjen M Dondorp, Francois Nosten, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancyJoel Tarning, Palang Chotsiri, Vincent Jullien, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|March 1, 2017
Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-PiperaquineJesmin Permala, Joel Tarning, François Nosten, et al.
Science Translational Medicine|October 31, 2014
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemopreventionMartin Bergstrand, François Nosten, Khin Maung Lwin, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2018
Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in HumansBenjamin Guiastrennec, David P Sonne, Martin Bergstrand, et al.
Journal of Clinical Pharmacology|October 26, 2021
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic PurpuraMartin Bergstrand, Emma Hansson, Bernard Delaey, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 28, 2025
The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder PerspectiveMarylore Chenel, Sylvain Fouliard, Emma Hansson, et al.
Therapeutic Drug Monitoring|November 23, 2011
Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearanceJohan E Wallin, Martin Bergstrand, Henryk E Wilczek, et al.
Malaria Journal|March 24, 2018
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern MyanmarJesmin Permala Lohy Das, Myat P Kyaw, Myat H Nyunt, et al.
The AAPS Journal|December 11, 2012
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patientsDinko Rekić, Daniel Röshammar, Martin Bergstrand, et al.
The AAPS Journal|September 13, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast AsiaJesmin Lohy Das, Arjen M Dondorp, Francois Nosten, et al.
Antimicrobial Agents and Chemotherapy|August 29, 2012
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancyJoel Tarning, Palang Chotsiri, Vincent Jullien, et al.
Pageof 4